Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis

BACKGROUND: Multiple sclerosis (MS) is the most common autoimmune disease of the central nervous system. There are at least 150 000 persons with MS in Germany. Recent years have seen the approval of new drugs against MS with various mechanisms of action and differing adverse effect profiles. METHODS...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Dtsch Arztebl Int
Autores principales: Havla, Joachim, Warnke, Clemens, Derfuss, Tobias, Kappos, Ludwig, Hartung, Hans-Peter, Hohlfeld, Reinhard
Formato: Artigo
Lenguaje:Inglês
Publicado: Deutscher Arzte Verlag 2016
Materias:
Review Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5282476/
https://ncbi.nlm.nih.gov/pubmed/28130920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3238/arztebl.2016.0879
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares